Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices.
about
Ebolavirus vaccines for humans and apesProspects for dengue vaccines for travelersVaccinations for pregnant womenEvaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countriesCase definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortiumRabies in nonhuman primates and potential for transmission to humans: a literature review and examination of selected French national dataA randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults.Stray dog trade fuelled by dog meat consumption as a risk factor for rabies infection in Calabar, southern NigeriaBat rabies in Guatemala.Expression of MIP-1alpha (CCL3) by a recombinant rabies virus enhances its immunogenicity by inducing innate immunity and recruiting dendritic cells and B cells.Enhancement of blood-brain barrier permeability is required for intravenously administered virus neutralizing antibodies to clear an established rabies virus infection from the brain and prevent the development of rabies in mice.Prophylaxis of human hydrophobia in South KoreaRabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination.Using serology to assist with complicated post-exposure prophylaxis for rabies and Australian bat lyssavirus.Investigating the role for IL-21 in rabies virus vaccine-induced immunity.Post-exposure treatment of Ebola virus using passive immunotherapy: proposal for a new strategy.Maxillofacial injuries due to animal bitesDog Bites among Off-Road Cyclists: A Report of Two CasesRabies in captive deer, Pennsylvania, USA, 2007-2010Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study.Community survey after rabies outbreaks, Flagstaff, Arizona, USA.Post-Marketing Surveillance of Human Rabies Diploid Cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990‒2015.Neutralizing Antibody Response after Intramuscular Purified Vero Cell Rabies Vaccination (PVRV) in Iranian Patients with Specific Medical Conditions.The Economics of a Successful Raccoon Rabies Elimination Program on Long Island, New YorkInadequate antibody response to rabies vaccine in immunocompromised patient.Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India.T-cell epitope vaccine design by immunoinformatics.B cell infection and activation by rabies virus-based vaccines.Factors Influencing Animal Bites in Iran: A Descriptive StudyThe burden of rabies in Tanzania and its impact on local communitiesRabies surveillance in the United States during 2013Rabies surveillance in the United States during 2010.Rabies surveillance in the United States during 2011.ICAM-1-based rabies virus vaccine shows increased infection and activation of primary murine B cells in vitro and enhanced antibody titers in-vivo.Household exposure and animal-bite surveillance following human rabies detection in Southern Ghana.Lyssaviruses and rabies: current conundrums, concerns, contradictions and controversies.Experimental rabies vaccines for humans.Using an Emergency Department Syndromic Surveillance System to Evaluate Reporting of Potential Rabies Exposures, Illinois, 2013-2015.Assessment of rabies exposure risk in a group of U.S. Air Force basic trainees - Texas, January 2014.Survival of rabid rabbits after intrathecal immunization.
P2860
Q24631696-1998BFA0-2241-49D2-9AC7-76645CCCBAD1Q26314423-E6286C8A-EE35-47AB-8B31-E99F26A225DCQ26860740-62BD9775-64E6-41CD-9F52-55711DDFD9A1Q27306442-4906933A-D8EB-43D8-BCEC-722EF76EB1EBQ28533795-2B2ED579-E619-42F1-BA4D-FC822C40CECDQ30821387-5C14F99A-2D91-4D30-9018-0353EC7BDD6BQ33723480-1B67C375-C205-4861-8516-E619D9134A40Q33751604-452BE0AF-DA24-4A36-95E7-E95D5534FA4AQ33981883-E6C00A83-0361-4824-B41A-B3B9FADBC894Q34120270-F9B4B073-9292-415D-A8ED-E0F0A2DABB76Q34225964-EE2D80C3-1E84-4FF9-B659-881664BE4A0BQ34303983-8C261C33-63F9-4560-B853-8DAAC9A49F79Q34529895-E7DC9868-CAB6-48A3-84FF-41E5A60D8437Q34613600-349428A7-01CB-4599-9C5E-8EA22D23D57AQ34630598-283BD0A5-6B5B-446A-9DE1-505A7CD3EF9BQ35107644-12A2E012-993D-4561-A400-5CE712A0F0D0Q35649922-65706FD7-739E-41EA-A8D5-3F5D21ED6125Q35840517-891492A2-57E3-4DFF-A773-0214DB3B51E5Q35845930-5480B9FB-5294-4F47-A791-D6E2672CB219Q35887112-32B0057E-00BB-4330-9C5C-8F61CACCE75AQ35979908-74FBD24D-7880-4F3B-AADF-20F20FB9EDB1Q36075411-72247D95-7566-4166-AB3A-D1EBDB11D283Q36126522-18A25EE9-6E01-4517-985D-7A27D62DD02FQ36217551-1324EDB5-D355-47A4-9DCF-90D2094C4A1AQ36221220-023AB46E-59EB-46E1-8910-8B6B08AF21B1Q36552888-DC83E872-6216-4B36-8380-10F1CFBD60EFQ36702419-803344A4-E5DA-446E-BF30-F485E0B961CEQ37123384-DDC2129C-FFCF-4919-A7D7-BAAAAE42E42EQ37239196-B530CED4-55FB-4DC2-82C5-19E53CB46157Q37288862-31239FD8-BFAB-4B53-A1BC-5986E6CDE33AQ37431476-1A8BD653-10D6-4E1E-BF6F-C0B73566D891Q37431482-1C17E6E6-6125-4CF9-AA9D-EA5E08D27F6EQ37431532-F3DB2774-A07D-4F29-814B-708933779798Q37529574-9F9707EB-3ACB-4667-A88A-BA41D71326E1Q37600665-48558031-DB43-4A0F-B7D8-D77E4262AEE6Q37664750-783BAF93-D551-4129-AD6E-A9793E129F30Q37798009-74FA043A-42E5-4D78-A3D4-E78352ECB13AQ38686453-D80F54A0-4F12-4161-8417-38A8CC589423Q39138412-229EDEE6-8C7F-40EE-8967-798FB139E057Q39278121-96A2109F-1EB1-4588-A0E5-AD4CA72CFA51
P2860
Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Use of a reduced (4-dose) vacc ...... tee on immunization practices.
@ast
Use of a reduced (4-dose) vacc ...... tee on immunization practices.
@en
Use of a reduced
@nl
type
label
Use of a reduced (4-dose) vacc ...... tee on immunization practices.
@ast
Use of a reduced (4-dose) vacc ...... tee on immunization practices.
@en
Use of a reduced
@nl
prefLabel
Use of a reduced (4-dose) vacc ...... tee on immunization practices.
@ast
Use of a reduced (4-dose) vacc ...... tee on immunization practices.
@en
Use of a reduced
@nl
P2093
P50
P1476
Use of a reduced (4-dose) vacc ...... ttee on immunization practices
@en
P2093
Catherine M Brown
Charles E Rupprecht
Deborah Briggs
Harry D Kerr
Paul R Cieslak
Richard Franka
Robin Levis
Samuel L Katz
Susan M Lett
William Schaffner
P50
P577
2010-03-01T00:00:00Z